IGF1 and acute lymphoblastic leukemia: We have shown that the combined inhibition of the IGF1/R and MEK pathways using AG1024 + U0126 can sensitize ALL cells in a synergistic manner with IR-induced DNA damage and can also potentiate the effects of core chemotherapy agents in vitro.